Comparison of embolic agents for varices during transjugular intrahepatic portosystemic shunt for variceal bleeding: Tissue gel or coil? | Zendy

Linfeng Zhou | Zendy; BinYan Zhong | Zendy; Hang Du | Zendy; Wansheng Wang | Zendy; Jian Shen | Zendy; Shuai Zhang | Zendy; Wan-Ci Li | Zendy; Hao-Huan Tang | Zendy; Peng Zhang | Zendy; Weihao Yang | Zendy; Xiaoli Zhu | Zendy

Open Access

Comparison of embolic agents for varices during transjugular intrahepatic portosystemic shunt for variceal bleeding: Tissue gel or coil?

Author(s) -

Linfeng Zhou,

BinYan Zhong,

Hang Du,

Wansheng Wang,

Jian Shen,

Shuai Zhang,

Wan-Ci Li,

Hao-Huan Tang,

Peng Zhang,

Weihao Yang,

Xiaoli Zhu

Publication year - 2020

Publication title -

journal of interventional medicine

Language(s) - English

Resource type - Journals

eISSN - 2096-3602

pISSN - 2590-0293

DOI - 10.1016/j.jimed.2020.08.008

Subject(s) - medicine , transjugular intrahepatic portosystemic shunt , hepatic encephalopathy , clinical endpoint , stent , thrombus , embolization , varices , portal hypertension , radiology , surgery , liver function , ascites , encephalopathy , occlusion , gastroenterology , cirrhosis , randomized controlled trial

We aimed to compare treatment efficacy, safety and material cost between tissue gel and coil regarding variceal embolization during transjugular intrahepatic portosystemic shunt (TIPS).Materials & Methods: This retrospective study including cirrhotic patients with variceal bleeding treated with TIPS combined with variceal embolization between January 2016 and August 2017. Patients were divided into three groups according to embolic agents used in variceal embolization: tissue gel group (Group A), combination group (Group B), and coil group (Group C). The primary endpoint was 1-year rebleeding rate after TIPS creation. The secondary endpoints included shunt dysfunction, overt hepatic encephalopathy, liver function, and embolic agents-related expense.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research